Understanding how obesity affects breathing and heart responses
Official title: Breathing & Blood Pressure
Run by Florida State University · NCT05632406 · Data updated 2026-11-12
This study looks at how being overweight affects breathing and heart responses during exercise to help understand the connection between obesity and heart health.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Florida State University Academic / other |
| Locations | 1 site (Tallahassee, Florida) |
| Status | Recruiting |
| Started | October 25, 2023 |
| Main results expected | June 30, 2027 |
| Study ends | June 30, 2027 |
| Registry record updated | October 7, 2026 |
| Trial ID | NCT05632406 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with a body mass index of 40 kg/m² or less who are weight stable.
✕Probably not a fit
Patients with significant cardiovascular, neurological, or metabolic illnesses, or those with a history of uncontrolled hypertension, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate the impact of obesity on cardiovascular responses during different breathing maneuvers in adults. It focuses on how higher body mass may influence breathing difficulties during exercise, potentially due to increased respiratory muscle workload. By analyzing heart and blood vessel responses during brief exercise and various breathing techniques, the study seeks to provide insights into the relationship between obesity and cardiovascular health.
Why it matters
Potential benefit: If successful, this study could enhance understanding of cardiovascular health in obese individuals, leading to better management strategies.
How similar studies have gone: While similar studies have explored the relationship between obesity and cardiovascular responses, this specific approach focusing on breathing maneuvers is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: • Body mass index values of ≤40 kg/m\^2 Exclusion Criteria: * Not weight stable (\<5% change in body mass over the past six months) * Overt cardiovascular, neurological, renal, liver, and/or metabolic illness (e.g., diabetes mellitus) * Current, or history of uncontrolled, Stage 2 hypertension (blood pressure \>140 / 90 mmHg; anti-hypertensive medications are permitted) * Diagnosed obstructive sleep apnea * Previous bariatric surgery * Diagnosis or signs (e.g., values below the lower limit of normal) of overt airway disease(s) * Current or recent (regular use within the past 6 months) use of tobacco or nicotine products (e.g., cigarettes, vaping) * Per the POWERbreathe® company: * Patients who have undergone recent abdominal surgery and those with abdominal hernia. * Asthma patients who have a very low symptom perception and suffer from frequent, severe exacerbations or with an abnormally low perception of dyspnoea. * If a patient is suffering from a ruptured eardrum or any other condition of the ear. * Patients with marked elevated left ventricular end-diastolic volume and pressure. * Patients with worsening heart failure signs and symptoms after a respiratory/inspiratory muscle training (IMT) session * If you are suffering from a cold, sinusitis, or respiratory tract infection, we advise that you do not use your POWERbreathe IMT device. * Individuals who are not yet adults (infants, children, teenagers) * Pregnant (self-reported and urine pregnancy test conducted), lactating (self-reported), or post-menopausal (self-reported) females * Prisoners
Where it's running
-
Florida State University
Tallahassee, Florida, United States Recruiting
Study contacts
- Principal investigator: Joseph Watso, PhD — Florida State University
- Study coordinator: Joseph Watso, PhD
- Email: jwatso@fsu.edu
- Phone: 850-644-5260
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Nutrition support to improve dietary diversity in adults who are underweight or overweight/obese
A community-based nutrition program will be tested in adults in Cambodia to see if it improves dietary diversity and if the program is acceptable and feasible to run.
-
Hesperidin for better thinking in overweight older adults
In adults aged 55–75 who are overweight, taking hesperidin or a placebo for 10 weeks will show whether the citrus flavonoid can improve thinking skills like memory, attention, and problem-solving.
-
MR-based performance tests for overweight and obesity
This study tests mixed reality versions of mobility tests to see if they match conventional assessments in adults who are overweight or obese.
-
DA-302168S in adults with overweight or obesity
A phase 3 trial in China is testing whether DA-302168S helps people who are overweight or obese lose weight compared with a placebo.
-
Metabolic Health Trajectories in Overweight Chinese Adults
This observational study follows overweight and obese Chinese adults to see how metabolic health changes over five years and whether people stay healthy, develop diabetes, or have complications.
-
Blood-count inflammation scores (SII and SIRI) to predict metabolic complications in adults with overweight or obesity
This project will test whether two blood-count-based scores (SII and SIRI) can help predict metabolic complications and treatment response in adults with overweight or obesity.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.